An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 10, 2013

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Ovarian Cancer
Trial Locations (30)

BA1 3NG

Royal United Hospital; Oncology Department, Bath

B18 7QH

City Hospital, Birmingham

BD9 6RJ

Bradford Royal Infirmary; Oncology Department, Bradford

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

DE13 0RB

Queen's Hospital; Oncology Department, Burton-on-Trent

CO3 3NB

Essex County Hospital, Colchester

BN21 2UD

Eastborne District General Hospital, Eastbourne

EX2 5DW

Wonford Hospital; Oncology Department, Exeter

GU2 7XX

Royal Surrey County Hospital, Guildford

IP4 5PD

Ipswich Hospital, Ipswich

BD20 6TD

Airedale General Hospital; Research Office Ward 12, Keighley

LS9 7TF

St James University Hospital, Leeds

SW3 6JJ

Royal Marsden Hospital - London, London

ME16 0FS

Maidstone Hospital; Kent Oncology Centre, Maidstone

M2O 4BX

Christie Hospital Nhs Trust; Medical Oncology, Manchester

L63 4JY

The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral

TS4 3BW

The James Cook University Hospital, Middlesbrough

HA6 2RN

Mount Vernon Hospital, Middlesex

PO30 5TG

St Mary's Hospital, Newport

NG5 1PB

City Campus; Academic Unit of Oncology, Nottingham

PO6 3LY

Queen Alexandra Hospital; Portsmouth Haematology & Oncology Centre, Level B, Portsmouth

S10 2SJ

Weston Park Hospital; Cancer Clinical Trials Centre, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

ST4 6QG

City General Hospital, Stoke-on-Trent

SM2 5PT

The Royal Marsden Hospital, Sutton

SA2 8QA

Singleton Hospital; Oncology, Swansea

TQ27AA

Torbay Hospital; Oncology Department, Torquay

TR1 3LQ

Royal Cornwall Hospital, Truro

WV10 0QP

New Cross Hospital; Deansley Centre, Wolverhampton

YO31 8HE

The York Hospital, York

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01863693 - An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) | Biotech Hunter | Biotech Hunter